Gorman EA, O’Kane CM, McAuley DF. Acute respiratory misery syndrome in adults: analysis, outcomes, long-term sequelae, and administration. Lancet. 2022;400(10358):1157–70.
Fan E, Brodie D, Slutsky AS. Acute respiratory misery syndrome: advances in analysis and remedy. JAMA. 2018;319(7):698–710.
Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P, et al. Advances in acute respiratory misery syndrome: specializing in heterogeneity, pathophysiology, and therapeutic methods. Sign Transduct Goal Ther. 2025;10(1): 75.
Bos LDJ, Ware LB. Acute respiratory misery syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400(10358):1145–56.
Solar ZC, Liao R, Xian C, Lin R, Wang L, Fang Y, et al. Pure pachypodol built-in, lung focused and inhaled lipid nanomedicine ameliorates acute lung harm by way of anti-inflammation and repairing lung barrier. J Management Launch. 2024;375:300–15.
Xu Y, Lv L, Wang Q, Yao Q, Kou L, Zhang H. Rising utility of nanomedicine-based remedy in acute respiratory misery syndrome. Colloids Surf B Biointerfaces. 2024;237: 113869.
Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute respiratory misery syndrome. Nat Rev Dis Primers. 2019;5(1):18.
Chen T, Zhu G, Meng X, Zhang X. Current developments of small molecules with anti-inflammatory actions for the remedy of acute lung harm. Eur J Med Chem. 2020;207: 112660.
Roquilly A, Jacqueline C, Davieau M, Mollé A, Sadek A, Fourgeux C, et al. Alveolar macrophages are epigenetically altered after irritation, resulting in long-term lung immunoparalysis. Nat Immunol. 2020;21(6):636–48.
Chen X, Tang J, Shuai W, Meng J, Feng J, Han Z. Macrophage polarization and its position within the pathogenesis of acute lung harm/acute respiratory misery syndrome. Inflamm Res. 2020;69(9):883–95.
Liang L, Peng W, Qin A, Zhang J, Chen R, Zhou D, et al. Intracellularly synthesized synthetic exosome treats acute lung harm. ACS Nano. 2024;18(32):21009–23.
Park MD, Silvin A, Ginhoux F, Merad M. Macrophages in well being and illness. Cell. 2022;185(23):4259–79.
Liang L, Xu W, Shen A, Fu X, Cen H, Wang S et al. Inhibition of YAP1 exercise ameliorates acute lung harm by promotion of M2 macrophage polarization. MedComm (2020). 2023, 4(3):e293.
Li X, Chen G, Zhou X, Peng X, Li M, Chen D, et al. Roles of Akirin1 in early prediction and remedy of graft kidney ischemia–reperfusion harm. Good Drugs. 2024;3(2): e20230043.
Li J, Jiang X, Li H, Gelinsky M, Gu Z. Tailoring supplies for modulation of macrophage destiny. Adv Mater. 2021;33(12): e2004172.
Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Sign Transduct Goal Ther. 2023;8(1): 207.
Liu C, Xi L, Liu Y, Mak JCW, Mao S, Wang Z, et al. An inhalable hybrid biomimetic nanoplatform for sequential drug launch and reworking lung immune homeostasis in acute lung harm remedy. ACS Nano. 2023;17(12):11626–44.
Zhu Q, Yu T, Gan S, Wang Y, Pei Y, Zhao Q, et al. TRIM24 facilitates antiviral immunity by mediating K63-linked TRAF3 ubiquitination. J Exp Med. 2020;217(7): e20192083.
Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 2019;10(1):4353.
Guan X, Xu X, Tao Y, Deng X, He L, Lin Z, et al. Twin focusing on and bioresponsive nano-PROTAC induced exact and efficient lung most cancers remedy. J Nanobiotechnol. 2024;22(1):692.
Huang JH, Huang CJ, Yu LN, Guan XL, Liang SW, Li JH, et al. Bioinspired PROTAC-induced macrophage destiny dedication alleviates atherosclerosis. Acta Pharmacol Sin. 2023;44(10):1962–76.
Kalluri R, LeBleu VS. The biology, operate, and biomedical purposes of exosomes. Science. 2020, 367(6478):eaau6977. https://doi.org/10.1126/science.aau6977
Zhu L, Tian W, Yuan L, Chi C, Wang Y, Xiao Q, et al. Aptamer-based extracellular vesicle isolation, evaluation and therapeutics. Interdiscip Med. 2023;1(2): e20220019.
Qiao R, Wang H, Li D, Yang Y, Shu J, Track X, et al. Stevioside protects towards acute kidney harm by inhibiting gasdermin D pathway. Good Drugs. 2024;3(2): e20240010.
Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, et al. Exosomes as a brand new frontier of most cancers liquid biopsy. Mol Most cancers. 2022;21(1):56.
Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for focused drug supply. Theranostics. 2021;11(7):3183–95.
Wang J, Yuan S, Tu Y, Lv Z, Cheng H, Ding X. Extracellular vesicles in pores and skin well being, illnesses, and ageing. Interdiscip Med. 2024;2: e20240011.
Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, et al. Exosome nanovesicles: a possible provider for therapeutic supply. Nano Right this moment. 2023;49:101771.
Gui X, Zhang H, Zhang R, Li Q, Zhu W, Nie Z, et al. Exosomes included with black phosphorus quantum dots attenuate retinal angiogenesis by way of disrupting glucose metabolism. Mater Right this moment Bio. 2023;19: 100602.
Wang P, Wang H, Huang Q, Peng C, Yao L, Chen H, et al. Exosomes from M1-polarized macrophages improve Paclitaxel antitumor exercise by activating macrophages-mediated irritation. Theranostics. 2019;9(6):1714–27.
Gunassekaran GR, Poongkavithai Vadevoo SM, Baek MC, Lee B. M1 macrophage exosomes engineered to foster M1 polarization and goal the IL-4 receptor inhibit tumor progress by reprogramming tumor-associated macrophages into M1-like macrophages. Biomaterials. 2021;278:121137.
Du T, Yang CL, Ge MR, Liu Y, Zhang P, Li H, et al. M1 macrophage derived exosomes irritate experimental autoimmune neuritis by way of modulating Th1 response. Entrance Immunol. 2020;11:1603.
Liu C, Zhang W, Li Y, Chang J, Tian F, Zhao F, et al. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated focusing on. Nano Lett. 2019;19(11):7836–44.
Zhang H, Mao Y, Nie Z, Li Q, Wang M, Cai C, et al. Iron oxide nanoparticles engineered macrophage-derived exosomes for focused pathological angiogenesis remedy. ACS Nano. 2024;18:7644–55.
Lin Y, Guan X, Su J, Chen S, Fu X, Xu X, et al. Cell membrane-camouflaged nanoparticles mediated nucleic acids supply. Int J Nanomedicine. 2023;18:8001–21.
Li H, Li S, Lin Y, Chen S, Yang L, Huang X, et al. Synthetic exosomes mediated spatiotemporal-resolved and focused supply of epigenetic inhibitors. J Nanobiotechnol. 2021;19(1):364.
Lan Q, Liu C, Yang F, Liu S, Xu J, Solar D. Synthesis of bilayer oleic acid-coated Fe3O4 nanoparticles and their utility in pH-responsive Pickering emulsions. J Colloid Interface Sci. 2007;310(1):260–9.
Zhang D, Teng KX, Zhao L, Niu LY, Yang QZ. Extremely-small nano-assemblies as tumor-targeted and renal clearable theranostic agent for photodynamic remedy. Adv Mater. 2023;35(19): e2209789.
Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary supply of SiRNA towards acute lung harm/acute respiratory misery syndrome. Acta Pharm Sin B. 2022;12(2):600–20.
Martin TR, Zemans RL, Ware LB, Schmidt EP, Riches DWH, Bastarache L, et al. New insights into scientific and mechanistic heterogeneity of the acute respiratory misery syndrome: abstract of the Aspen Lung Convention 2021. Am J Respir Cell Mol Biol. 2022;67(3):284–308.
Qiao Q, Liu X, Yang T, Cui Ok, Kong L, Yang C, et al. Nanomedicine for acute respiratory misery syndrome: the most recent utility, focusing on technique, and rational design. Acta Pharm Sin B. 2021;11(10):3060–91.
Liao R, Solar ZC, Wang L, Xian C, Lin R, Zhuo G, et al. Inhalable and bioactive lipid-nanomedicine primarily based on Bergapten for focused acute lung harm remedy by way of orchestrating macrophage polarization. Bioact Mater. 2025;43:406–22.
Békés M, Langley DR, Crews CM. Protac focused protein degraders: the previous is prologue. Nat Rev Drug Discov. 2022;21(3):181–200.
Huang J, Yao Z, Li B, Ping Y. Focused supply of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted most cancers remedy. J Management Launch. 2023;361:270–9.
Yang L, Yang Y, Zhang J, Li M, Yang L, Wang X, et al. Sequential responsive nano-PROTACs for exact intracellular supply and enhanced degradation efficacy in colorectal most cancers remedy. Sign Transduct Goal Ther. 2024;9(1): 275.
Zhang HT, Peng R, Chen S, Shen A, Zhao L, Tang W, et al. Versatile nano-PROTAC-induced epigenetic reader degradation for environment friendly lung most cancers remedy. Adv Sci. 2022;9(29):e2202039.
Zhang Y, Liu Q, Zhang X, Huang H, Tang S, Chai Y, et al. Current advances in exosome-mediated nucleic acid supply for most cancers remedy. J Nanobiotechnol. 2022;20(1):279.
Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, et al. Exosome-mediated supply of gene vectors for gene remedy. Nanoscale. 2021;13(3):1387–97.
Zhang L, Lin Y, Li S, Guan X, Jiang X. In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes. Angew Chem Int Ed. 2023;62(11): e202217089.
Lin Y, Yi M, Guan X, Chen E, Yang L, Li S, et al. Two birds with one stone technique for the lung most cancers remedy with bioinspired AIE aggregates. J Nanobiotechnol. 2023;21(1):49.
Tian Y, Han W, Yeung KL. Magnetic microsphere scaffold-based tender microbots for focused mesenchymal stem cell supply. Small. 2023;19(32): e2300430.
Li N, Fei P, Tous C, Rezaei Adariani M, Hautot ML, Ouedraogo I, et al. Human-scale navigation of magnetic microrobots in hepatic arteries. Sci Robotic. 2024;9(87): eadh8702.
Chen J, Ren T, Xie L, Hu H, Li X, Maitusong M, et al. Enhancing aortic valve drug supply with PAR2-targeting magnetic nano-cargoes for calcification alleviation. Nat Commun. 2024;15(1):557.
Zhang H, Li Z, Gao C, Fan X, Pang Y, Li T, et al. Twin-responsive biohybrid neutrobots for lively goal supply. Sci Robotic. 2021;6(52): eaaz9519.
Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and different extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17.
Nowak-Jary J, Machnicka B. Pharmacokinetics of magnetic iron oxide nanoparticles for medical purposes. J Nanobiotechnol. 2022;20(1):305.
Zhao D, Zhu T, Li J, Cui L, Zhang Z, Zhuang X, Ding J. Poly(lactic-co-glycolic acid)-based composite bone-substitute supplies. Bioact Mater. 2021;6(2):346–60.
